Invited commentary: Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
Machado N, Wilhelm S.
Am J Surg. 2020 Nov;220(5):1167-1168. doi: 10.1016/j.amjsurg.2020.07.012. Epub 2020 Jul 16.
Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review.
Vargas-Pinto S, Romero Arenas MA.
J Surg Res. 2019 Oct;242:244-251. doi: 10.1016/j.jss.2019.04.036. Epub 2019 May 16.
Total thyroidectomy versus lobectomy for papillary thyroid cancer: A systematic review and meta-analysis.
Zhang C, Li Y, Li J, Chen X.
Medicine (Baltimore). 2020 Feb;99(6):e19073. doi: 10.1097/MD.0000000000019073.
Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
Wilson M, Patel A, Goldner W, Baker J, Sayed Z, Fingeret AL.
Am J Surg. 2020 Nov;220(5):1169-1173. doi: 10.1016/j.amjsurg.2020.06.052. Epub 2020 Jul 1.
Reoperation Rates After Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study.
Kheng M, Manzella A, Chao JC, Laird AM, Beninato T.
Thyroid. 2024 Aug;34(8):1007-1016. doi: 10.1089/thy.2024.0128.
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy.
Wu Z, Tian Y, Chen Z, Su A.
J Vis Exp. 2023 May 12;(195). doi: 10.3791/64437.
Risk Assessment in Thyroid Lobectomy and Total Thyroidectomy using Over 100 Thousand Cases.
Brauer PR, Burkey BB, Reddy CA, Lamarre ED.
Ann Otol Rhinol Laryngol. 2021 Dec;130(12):1351-1359. doi: 10.1177/00034894211007219. Epub 2021 Apr 9.
Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
Youssef MR, Attia AS, Omar M, Aboueisha M, Freeman MN, Shama M, Kandil E.
Surgery. 2022 Jan;171(1):190-196. doi: 10.1016/j.surg.2021.05.057. Epub 2021 Aug 10.
Radioiodine Ablation of Remaining Thyroid Lobe in Patients with Differentiated Thyroid Cancer Treated by Lobectomy: A Systematic Review and Metaanalysis.
Piccardo A, Trimboli P, Bottoni G, Giovanella L.
J Nucl Med. 2020 Dec;61(12):1730-1735. doi: 10.2967/jnumed.120.244384. Epub 2020 Apr 24.
Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers.
Rajjoub SR, Yan H, Calcatera NA, Kuchta K, Wang CE, Lutfi W, Moo-Young TA, Winchester DJ, Prinz RA.
Surgery. 2018 May;163(5):1134-1143. doi: 10.1016/j.surg.2017.12.026. Epub 2018 Feb 13.
